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e.2012.09Abstract Background: Soft tissue sarcomas like other malignancies, impact negatively on patients
and their caregivers as well as pose a challenge to the managing physician with variable treatment
outcomes. A review of related studies on Medline has shown the paucity of the literature on the
disease in the West African sub-region. This study was designed to determine the prevalence and
highlight the clinicopathologic features of soft tissue sarcomas managed at a tertiary health institu-
tion in West Africa.
Methods: A 12-year retrospective review of medical records of patients managed with head and
neck sarcomas at the University College Hospital, Ibadan, Nigeria was carried out.
Results: There were 18 patients [12 (66.7%) males & 6 (33.3%) females]; ages ranging from 3 to
58 years. 16.7% of patients was children. The mean duration of symptoms was 10.5 months. The
clinical presentation depended on the involved anatomical location and the most common anatom-
ical location was the sinonasal region. Fourteen (77.8%) patients presented at advanced disease
stage. Eight histologic sub-types were identiﬁed and rhabdomyosarcoma accounted for 44.4%.
The treatment outcome was poor.
Conclusion: Head and neck sarcomas are rare in West Africa. They have heterogeneous histologic
sub-types which may involve different anatomic sites. Although the prognoses of some sarcomas of
the head and neck are poor due to their biological behaviours, late stage disease presentation might
have contributed to the worse management outcome seen in this study.
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m (A.J. Fasunla).
xandria University Faculty of
g by Elsevier
y Faculty of Medicine. Production
.0011. Introduction
Sarcomas are malignant neoplasms derived from the connec-
tive elements of soft or bony tissues in the body. They are rare,
accounting for approximately 1% and 6.5% of all head and
neck neoplasms in adults and children respectively.1–3 Soft tis-
sue sarcomas account for the majority (80%) of all sarcomas in
the body and constitute about 20% of all sarcomas affectingand hosting by Elsevier B.V. All rights reserved.
44 A.J. Fasunla, A. Danielthe head and neck regions in adults and approximately 35% in
children.4,5 The face and neck are the most frequent sites af-
fected in the head and neck.6
Soft tissue sarcomas arise from the mesenchymal deriva-
tives which include muscular, ﬁbrous, fatty, synovial, vascular
or neural tissues.7,8 They exhibit varied biological activities
that ranged from slow to aggressive tumour growths, associ-
ated with regional and systemic metastases.9 They tend to
grow in the path of least resistance and push the surrounding
tissues. The pseudo-capsules of these tumours usually contain
invasive tumours and may explain the frequently encountered
local recurrence. Distant metastasis is very rare and only oc-
curs in high grade primary lesions.10,11
The exact cause of sarcomas of the head and neck is not
known but factors such as exposure to chlorophenols in wood
preservatives, phenoxy herbicides, vinyl chloride used in the
manufacture of plastics and ultraviolet irradiation have been
implicated. Infections with human papilloma virus (HPV)
and human immunodeﬁciency virus (HIV) and genetic alter-
ation of the p53 gene (Li-Fraumeni syndrome) have also been
suggested.
Establishing the tumour size, histologic type, grade and
stage before deﬁnitive treatment is also necessary in soft tissue
sarcomas because they are important prognostic factors in
malignant tumours. Tumour grading is based on Trojani clas-
siﬁcation which depends on tumour differentiation, mitosis
count and tumour necrosis12 while the staging is by the Union
Internationale Contre le Cancer (UICC) or American Joint
committee on Cancer (AJCC) classiﬁcation which is based on
tumour size, regional lymph node status, grade and distant
metastases.13,14 Enneking’s classiﬁcation which relies on resec-
tion margins or amputation is more appropriately used to stage
sarcomas of the extremities.15 Stages III and IV, where the tu-
mour may be more than 5 cm in size, presence of lymph node or
distant metastasis can be regarded as advanced disease stages.
The treatment modalities of sarcomas commonly include
surgery, chemotherapy and radiotherapy or a combination of
these depending on the histologic type and disease stage.11
Head and neck sarcomas impact on the patients’ quality of
life and also on their family members who provide care for
them. It also poses a big challenge to the managing physicians.
This is demonstrated more in resource challenged environ-
ments where there is scarcity of immunohistochemical studies
thereby leading to misdiagnosis and under reported cases.
The review of related studies on Medline has shown the pau-
city of literature on the disease in the West African sub-region.
The aim of this study therefore was to report on soft tissue sar-
comas of the head and neck in a tertiary health institution in
West Africa.
2. Materials and methods
This is a 12-year retrospective study of all patients managed
for histologically diagnosed soft tissue sarcomas of the head
and neck at the Otorhinolaryngology Department of the
University College Hospital, Ibadan, Nigeria from January
2000 to December 2011. This is a leading tertiary health
institution in Nigeria that receives cancer patients’ referral
from primary and secondary health institutions located in
different parts of the country due to its medical and radio-
therapy facilities.Data collected from the medical records of the patients and
Ibadan cancer registry records included demographic data
(age, sex), level of education, occupation, presenting symptoms
and their duration, anatomical location of the primary tu-
mour, tumour characteristics (clinical staging and histologic
subtypes) and treatment. The socioeconomic status was esti-
mated from the patients’ or their parents’ level of education
and occupation. Five social classes (I, II, III, IV & V) were de-
ﬁned and class I represents the highest socioeconomic class
while class V represents the lowest socioeconomic class.16
Those with incomplete clinical entries or without histological
reports were excluded from this study. The clinical photo-
graphs of the patients were taken after permission and consent
was obtained from them or their care givers at their ﬁrst hos-
pital visit and stored. The data were analysed using a simple
descriptive method and the results were presented in tabular
forms.
3. Results
There were 18 patients with histologically diagnosed soft tissue
sarcomas of the head and neck. This constituted 77.8% of all
the head and neck sarcomas and 1.6% of all head and neck
malignancies managed during the study period. There were
12 (66.7%) males and 6 (33.3%) females with a male: female
sex ratio of 2:1. The age of the patients ranged from 3 to
58 years with a mean age of 37.3 years and median age of
42 years. Three (16.7%) patients were children with histologi-
cal diagnosis of embryonal rhabdomyosarcoma.
The duration of symptoms at presentation ranged between
4 and 25 months, with a mean of 10.5 months and median
was 9.5 months. Six (33.3%) patients belonged to class V, 9
(50.0%) patients belonged to class IV, 1 (5.6%) patient be-
longed to class III and 2 (11.1%) patients belonged to socioeco-
nomic class I. The distribution of the patients’ age, anatomical
locations, histopathologic subtypes, duration of symptoms,
socioeconomic class and stage of the disease is shown in
Table 1. The most common anatomical location affected was
the sinonasal region constituting 33.3% of the soft tissue head
and neck sarcomas while ear, larynx and parapharyngeal space
had the lowest frequency of involvement (Table 1).
Six (33.3%) patients presented with painful masses. Pa-
tients with sinonasal soft tissue sarcomas commonly presented
with unilateral epistaxis, facial asymmetry, nasal growth and
blockage (Fig. 1a and e).
One patient had an extension of the tumour to the ipsilat-
eral orbit with loss of vision in that eye. The patient with para-
pharyngeal sarcoma presented with a unilateral progressively
increasing cervical mass, dysphagia and features of upper air-
way obstruction. The patients with oropharyngeal sarcoma
presented with tonsillar masses, blood stained saliva, progres-
sive dysphagia, change in voice and cervical lymphadenopathy.
The patient with synovial cell sarcoma of the larynx presented
with hoarseness and features of upper airway obstruction. The
three year old boy with rhabdomyosarcoma of the ear pre-
sented with blood stained ear discharge, periauricular swelling
and facial palsy (Fig. 1f). There was ulceration of the cervical
myxoﬁbrosarcoma and subsequently its rapid, accelerated
growth after incisional biopsy was performed at an outside
health facility (Fig. 1d). The patient with the facial dermatoﬁ-
brosarcoma had repeated excisions of the lesion at a peripheral
Table 1 Distribution of the head and neck sarcomas and their anatomical locations.
Age Sex Tumour location Histology Duration of
symptoms
(months)
Socioeconomic
class
Stage of the
disease
Treatment
outcome
3 M Ear Embryonal rhabdomyosarcoma 8 IV Stage IV Dead
4 M Cervico-facial Embryonal rhabdomyosarcoma 10 V Stage III Dead
11 M Sinonasal Embryonal rhabdomyosarcoma 4 I Stage I Alive
(without evidence of
recurrence)
19 M Larynx Synovial cell sarcoma 7 IV Stage III Dead
22 F Sinonasal Alveolar rhabdomyosarcoma 9 V Stage III Dead
26 M Cervico-facial Alveolar rhabdomyosarcoma 10 IV Dead
36 F Sinonasal Malignant peripheral nerve
sheath tumour
17 V Stage IV Dead
38 M Neck Myxoﬁbrosarcoma 11 IV Stage III Dead
41 F Face Malignant ﬁbrous histiocytomas 10 IV Stage III Dead
43 F Parapharyngeal Malignant peripheral nerve
sheath tumour
12 IV Stage III Dead
47 M Face Dermatoﬁbrosarcoma protruberans 25 V Stage I Alive
(without evidence of
recurrence)
51 M Neck Botyroid rhabdomyosarcoma 7 III Stage III Dead
52 M Sinonasal Malignant ﬁbrous histiocytomas 6 I Stage II Dead
54 M Sinonasal Sinonasal haemangiopericytoma 12 IV Stage III Dead
54 F Oropharynx Alveolar rhabdomyosarcoma 9 V Stage IV Dead
56 M Sinonasal Kaposi’s sarcoma 13 V Stage III Dead
57 M Neck Malignant ﬁbrous histiocytomas 11 IV Stage II Alive
(with recurrence)
58 F Oropharynx Alveolar rhabdomyosarcoma 8 IV Stage II Alive
(with recurrence)
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seen in 5 (27.8%) of the patients. Two (0.1%) patients also
presented with pulmonary metastasis. Two patients with intra-
cranial extension of sinonasal rhabdomyosarcoma on comput-
erized tomographic (CT) scan did not present with symptoms
of raised intracranial pressure or lateralizing sign as the tumors
were still conﬁned to extradural space.
The diagnosis of soft tissue sarcomas was by histopathol-
ogy and immunohistochemical analyses. There were eight
histopathologic variants of soft tissue sarcomas found in this
study and the most common type was rhabdomyosarcoma
constituting 44.4% of the cases, followed by malignant
ﬁbrous histiocytomas which formed 16.7% of the cases
(Table 1).
Fourteen (77.8%) patients presented at advanced disease
stage because the sarcoma was large in size and/or had spread
to involve other adjacent structures. Eight (44.4%) patients
had some form of tumour resection and neck dissection. How-
ever, complete primary tumour resection with free margins
could not be achieved due to the large tumour size and involve-
ment of adjacent vital structures. Those with intracranial
extension of the tumour had craniotomy and excision of the
intracranial component in conjunction with the Neurosur-
geons. The patient with orbital extension had orbital exenter-
ation along with total maxillectomy. Only one patient with
sinonasal alveolar rhabdomyosarcoma had localized disease
that was completely resected with clear margins. All the pa-
tients had adjuvant chemotherapy and radiation therapy.
The patients with unresectable tumours had palliative chemo-
therapy and radiotherapy.The treatment outcomes of these patients were poor. At the
time of this study, only 4 (22.2%) of these patients were alive
and still being followed-up after two years of diagnosis and
treatment (Table 1). However, two of them had already devel-
oped local and regional recurrences. The remaining two
patients (a 47 year old man with dermatoﬁbrosarcoma pro-
truberans of the face and the 11 year old boy with sinonasal
rhabdomyosarcoma) are without clinical and radiological evi-
dence of recurrence till date. The remaining 14 (77.8%) pa-
tients died from the disease progression within one year of
diagnosis.4. Discussion
In this present study, soft tissue sarcomas of the head and neck
constituted 77.8% of all head and neck sarcomas and 1.6% of
all head and neck malignancies managed during the study per-
iod. This ﬁnding is similar to what had been previously re-
ported in the literature.1–3 The predominance of males seen
in this study is similar to other reports in the literature.6,11
However, the study by de Bree et al. reported female predom-
inance.17 This present study showed that soft tissue sarcomas
were commoner in young and middle age groups. In similar
previous studies of adult head and neck sarcomas, it has been
frequently reported in the middle age group.2,3,6,18 Head and
neck sarcomas in children are also reported in this present
study with all the patients diagnosed with rhabdomyosarcoma.
Rhabdomyosarcoma is the most frequent soft tissue sarcoma
in the paediatric age group.19 The three year old boy with
Figure 1 Clinical photographs of some patients with soft tissue sarcomas.
46 A.J. Fasunla, A. Danielrhabdomyosarcoma of the ear presented with symptoms mim-
icking complicated suppurative otitis media. It was after tissue
histology from mastoidectomy that the diagnosis was made.
Sarcomas should therefore be considered for differential
diagnosis in a patient with blood stained mucoid ear discharge,
facial nerve palsy and progressive periauricular swelling which
does not improve with medical treatment.
Early detection and diagnosis is very essential for good
treatment outcome. The average duration at presentation in
this study was 10.5 months. In a similar study by Colville from
Newcastle, United Kingdom on 60 patients with head and
neck sarcomas, the mean duration of symptoms was
8.5 months.11 This delay usually results in poor clinical and
treatment outcome because the disease would have signiﬁ-
cantly advanced and obtaining a negative resection margin
may be difﬁcult without sacriﬁcing a vital organ. In our envi-
ronment, the delay in presentation to hospitals could be attrib-
uted, not only to the nonspeciﬁc nature of the commonly
encountered head and neck lumps at an early stage1,2 but also
to the socio-cultural beliefs and practices of the people. These
factors include self medication, wrong advice from relations
and friends to consult traditional herbalists and quacks for
treatment as well as traditional & religious beliefs (i.e. that
the head and neck sarcoma was due to some form of ‘‘spiritual
attack’’). Therefore, aggressive health education that will cor-
rect these beliefs and practices and, will bring about a change
in attitude to health is essential. In addition, contemporary
radiologic examination tools such as computerized tomo-
graphic (CT) scan and magnetic resonance imaging (MRI),
which are effective tools for the early detection of these lesions,
are not readily available and affordable in most practices in the
West African sub-region. It has however been recommended
that patients with an unexplained lump in the neck which
has recently appeared or undergone rapid growth should be re-
ferred to an oncology centre for the evaluation of soft tissue
sarcomas.20 Multidisciplinary team approach management
has also been recommended.11,21The general observation of the patients’ occupational clas-
ses showed that there were more patients in lower occupational
classes than those in the upper classes. The higher number of
patients from the lower socio-economic class in this study
may be a reﬂection of many people in the lower socioeconomic
class in West Africa. Generally, it is believed that people in the
upper socio-economic classes are more literate, have healthier
lifestyles and behaviour than people in the lower classes.22 This
could also be a reason for this observation in this study.
Although the exact cause of soft tissue sarcomas of the head
and neck is not known, few predisposing factors have been re-
ported but none of the patients in this study had an occupation
that could expose them to these factors. Previous exposure to
radiation is an important predisposing factor especially for
malignant ﬁbrous histiocytomas but none of the three patients
with malignant ﬁbrous histiocytomas in this study had such a
history. Only one patient with Kaposi sarcoma of the sinona-
sal region had a human immunodeﬁciency virus (HIV) infec-
tion. Kaposi sarcoma is the soft tissue sarcoma that
sometimes develops in people with HIV infection.23 The possi-
bility of infection by Human Papilloma Virus could not be ver-
iﬁed in the patients as this is not routinely examined in our
centre. Our impression was that the factors that predispose
our patients to the disease were yet to be identiﬁed. Further
studies may be indicated in order to ﬁnd out these factors in
our environment.
The clinical presentations of the patients with soft tissue
sarcomas of head and neck depend on the involved anatomic
sites and direction of spread. Few of the patients in this study
presented with pain which might have been due to the sheer
size of the mass and/or the pathological changes like infection
or bleeding occurring within the tumour mass.
Soft tissue sarcomas can arise from both the soft tissues and
organs of the head and neck. Previous similar studies have
reported face and neck as the most frequently affected anatom-
ical sites.6,11 The most common anatomical location of the
tumour in this study was the sinonasal region (Table 1). This
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with regard to the anatomical site of tumour origin. The other
previous similar studies did not have sinonasal as the anatomic
site and it is possible that they have incorporated the sinonasal
site as part of the sarcomas of the face since the tumour can
extend to involve soft tissue of the face (Fig. 1a). Neck alone
or with face (cervicofacial) is the second most frequently in-
volved anatomic site in this study (Table 1). Sarcomas of the
head and neck present commonly with local and regional
spreads because their pseudo-capsules contain invasive tumour
cells.10,11 This promotes tumour spread in the path of least
resistance by eroding or compressing on adjacent structures
leading to its rapid development to larger size.
There are many histologic variants of soft tissue sarcomas
and the extreme complexity of the histology types requires
histopathology and immunohistochemical analyses to distin-
guish the different subtypes.24 In this present study, only eight
histopathologic variants of soft tissue sarcomas were found.
More than 50 subtypes of soft tissue sarcomas have been
documented in the literature which showed their histological
heterogeneity.25,26 The fewer histopathologic subtypes of soft
tissue sarcomas from this study may be due to the non-
availability of immunohistochemical analysis and its expertise
at the study centre especially during the early part of the
study period. Some of these soft tissue sarcomas might have
been missed. The most common histologic sub-type in our
study was rhabdomyosarcoma, constituting 44.4% of the
cases (Table 1). This frequency of rhabdomyosarcoma in this
study is higher than what other similar studies have re-
ported.1,5,6,8,11,27 This may be due to the inclusion of children
in this present study. Rhabdomyosarcoma is the commonest
soft tissue sarcoma in the paediatric age group and is associ-
ated with distinct genetic alterations.19 In addition, few of
these previous studies incorporated other non-soft tissue
sarcomas and this might have contributed to the reduced
frequency of rhabdomyosarcoma reported in them. Three his-
tologic sub-types of rhabdomyosarcomas were identiﬁed in
this study and 50% of which was alveolar rhabdomyosar-
coma. The embryonic subtype was found only in the paediat-
ric age group. Historically, rhabdomyosarcomas is known to
have poor prognosis because of its relative resistance to radio-
therapy. However, systemic chemotherapy, with or without
radiotherapy and surgery are recommended as the mainstay
of treatment.28 More often, this is not possible in our setting
because patients usually present in advanced disease stage
when multiple vital structures in the head and neck region
are already affected.
Malignant ﬁbrous histiocytomas is the second most fre-
quent histologic subtype, constituting 16.7% of all sarcomas
in this study. Varied frequencies of this tumour have been
reported in the literature while a few studies did not report
it.6,8,11,24,27,29 Usually, it arises at a variety of sites in the head
and neck region, notably in the salivary glands, soft tissues of
the cheek and mouth, the orbit, the meninges and in the sin-
onasal tract.29–31 The tumour is usually induced by exposure
to radiation. Malignant peripheral nerve sheath tumour is the
third most common sarcoma in this study. It is the single
most common primary fascicular spindle cell sarcoma in
the head and neck region that occurs mainly in adults and
shows a predilection for the sinonasal region.30 Its spread
through the lymphatics in the head and neck is rare.24,32
About 5% of dermatoﬁbrosarcoma protuberans arise in thehead and neck region and often affect young to middle-aged
adults with a male predominance. Its common locations are
scalp and cheek. It is a low grade neoplasm with good
response to treatment and has a better prognosis than other
sarcomas. The only case of dermatoﬁbrosarcoma protuberans
of the face in this study was in a 47 year old male (Fig. 1e).
Biologically, dermatoﬁbrosarcoma protuberans exhibit more
of a plaque like, diffuse pattern of growth other than the
exophytic nodularity in the head and neck. However, its
histologic appearances in the head and neck are similar to
what was obtained in other parts of the body.31 It has a
locally aggressive behaviour but usually does not metastasise.
Sarcomas originating from the larynx are rarely reported in
the literature. Chondrosarcomas are the commonest sarcomas
of the larynx.33 Synovial cell sarcoma of the larynx diagnosed
in a 19 year old man in this study is very rare and this makes it
not to be readily considered as a differential diagnosis of
malignant laryngeal tumour. The other histologic variants seen
in this study were as shown in Table 1.
The treatments received by our patients were not differ-
ent from what had earlier been reported by other similar
studies.2,5,6,27,28 Complete surgical excision of the sarcomas
offers the only realistic chance for long term survival. It is
however difﬁcult to achieve a negative resection margin in
head and neck sarcomas.18 The modalities of treatment in
this study included a combination of tumour resection with
radiotherapy and/or chemotherapy in 12 (66.7%) patients
and the remaining 6 (33.3%) patients had a combination
of radiotherapy and systemic chemotherapy either because
they were inoperable due to the proximity of vital structures
to the mass or advanced disease stage. In those who had
surgical resection of the tumour, a negative margin was
possible only in a patient who presented at the early disease
stage.
Early presentation, availability of investigative tools and
improved therapy will bring about better treatment outcome.
The reported prevalence of live, disease free patients with head
and neck sarcomas varied from 41.6% to 60%.6,8,11,17,18,34,35
Irregular and inconsistent irradiation therapy received by the
patients due to frequent technical faults developed by the
radiotherapy machine and incessant power outage in our
hospital also might have contributed to the worse treatment
outcome observed in this study.
5. Conclusion
The 12 years retrospective review showed that soft tissue sarco-
mas of the head and neck are rare in West Africa. They have
heterogeneous histologic sub-types which may involve differ-
ent anatomic locations in the head and neck region. Although
the prognoses of some sarcomas of the head and neck are poor
due to their biological behaviours, late stage disease presenta-
tion might have contributed to the worse management out-
come seen in this study.Acknowledgements
We thank the consultant ENT surgeons whose patients’ data
were used in this study as well as the medical records ofﬁcers
for their assistance in the retrieval of the patients’ medical
records.
48 A.J. Fasunla, A. DanielReferences
1. Chen SA, Moris CG, Amdur RJ, Werning JW, Villaret DB,
Mendenhall WM. Adult head and neck soft tissue sarcomas. Am J
Clin Oncol 2005;28:259–63.
2. Mendenhall WM, Mendenhall CM, Werning JW, Riggs CE,
Mendenhall NP. Adult head and neck soft tissue sarcomas. Head
Neck 2005;27:916–22.
3. Huber GF, Mathews TW, Dort JC. Soft tissue sarcomas of the
head and neck: a retrospective analysis of the Alberta experience
1974 to 1999. Laryngoscope 2006;116:708–15.
4. Sturgis EM, Potter BO. Sarcoma of the head and neck. Curr Opin
Oncol 2003;15:239–52.
5. Yamaguchi S, Nagasawa H, Suzuki T, Fujii E, Iwaki H, Takagi
M, et al. Sarcomas of the oral and maxillofacial region: a review
of 32 cases in 25 years. Clin Oral Invest 2004;8:52–5.
6. Pacheco IA, Alves AP, Mota MR, Almeida PC, Holanda ME,
Souza EF, et al. Clinicopathological study of patients with head
and neck sarcomas. Braz J Otorhinolaryngol 2011;77:385–90.
7. Gorsky M, Epstein JB. Head and neck and intra-oral soft tissue
sarcomas. Oral Oncol 1998;34:292–6.
8. Bentz BG, Singh B, Woodruff J, Brennan M, Shah JP, Kraus D.
Head and neck soft tissue sarcoma: a multivariate analysis of
outcome. Ann Surg Oncol 2005;11:619–28.
9. Pellitteri PK, Ferlito A, Bradley PJ, Shaha AR, Rinaldo A.
Management of sarcomas of the head and neck in adults. Oral
Oncol 2003;39:2–12.
10. Kraus DH. Sarcomas of the head and neck. Curr Oncol Rep
2002;4:68–75.
11. Colville RJ, Charlton F, Kelly CG, Nicoll JJ, McLean NR.
Multidisciplinary management of head and neck sarcomas. Head
Neck 2005;27:814–24.
12. Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Binh
Bui N, et al. Reproducibility of a histopathological grading
system for adult soft tissue sarcomas. Cancer 1986;58:306.
13. Sobin LH, Wittekind CH. UICC TNM classiﬁcation of malignant
tumors. New York: John Wiley & Sons, Inc.; 1997, p. 101–9.
14. Soft tissue sarcoma, . In: Edge SB, Byrd DR, Compton CC, et al.,
editors. AJCC cancer staging manual. 7th ed. New York, NY:
Springer; 2010. p. 291–6.
15. Simon MA, Enneking WF. The management of soft-tissue
sarcomas of the extremities. J Bone Joint Surg 1976;58A:317–27.
16. Hollingshead A. Two factor index of social position. New Haven,
CT: Yale University Press; 1957.
17. de Bree R, van der Valk P, Kuik DJ, van Diest PJ, Doornaert P,
Buter J, et al. Prognostic factors in adult soft tissue sarcomas of
the head and neck: a single-centre experience. Oral Oncol
2006;42:703–9.
18. Dudhat SB, Mistry RC, Varughese T, Fakih AR, Chinoy RF.
Prognostic factors in head and neck soft tissue sarcomas. Cancer
2000;89:868–72.19. Arndt CAS, Crist WM. Common musculoskeletal tumors of
childhood and adolescence. N Engl J Med 1999;341:342–52.
20. National Institute for Health and Clinical Excellence. Referral
guidelines for suspected cancer. <http://www.nice.org.uk/niceme-
dia/live/10968/52088/52088>; 2005.
21. Harb WJ, Luna MA, Patel SR, Ballo MT, Roberts DB, Sturgis
EM. Survival in patients with synovial sarcoma of the head and
neck: association with tumour location, size and extension. Head
Neck 2007;29:731–40.
22. Isaacs SL, Schroeder SA. Class – the ignored determinant of the
nation’s health. N Engl J Med 2004;351:1137–42.
23. Epstein JB, Silverman S. Head and neck malignancies associated
with HIV infection. Oral Surg Oral Med Oral Pathol 1992;83:
193–200.
24. Wick MR. Malignant peripheral nerve sheath tumours of the skin.
Mayo Clin Proc 1990;65:279–82.
25. Lahat G, Lazar A, Lev D. Sarcoma epidemiology and etiology:
potential environmental and genetic factors. Surg Clin N Am
2008;88:451–81.
26. Lajer CB, Daugaard S, Hansen HS, Kirkegaard J, Holmgaard
ME, Christensen ME. Soft tissue sarcomas of the head and
neck: a single-centre experience. Clin Otolaryngol 2005;30:
176–82.
27. Penel N, Van Haverbeke C, Lartigau E, Vilain MO, Ton Van J,
Mallet Y, et al. Head and neck soft tissue sarcomas of adult:
prognostic value of surgery in multimodal therapeutic approach.
Oral Oncol 2004;40:890–7.
28. Raney RB, Anderson JR, Barr FG, Donaldson SS, Pappo AS,
Qualman SJ, et al. Rhabdomyosarcoma and undifferentiated
sarcoma in the ﬁrst two decades of life: a selective review of
intergroup rhabdomyosarcoma study group experience and ratio-
nale for intergroup rhabdomyosarcoma study V. J Pediatr
Hematol Oncol 2001;23:215–20.
29. Chan JK. Solitary ﬁbrous tumour––everywhere and a diagnosis in
vogue. Histopathology 1997;31:568–76.
30. Nascimento AG. Solitary ﬁbrous tumour: a ubiquitous neo-
plasm of mesenchymal differentiation. Adv Anat Pathol 1996;3:
388–95.
31. Fletcher CDM. Distinctive soft tissue tumors of the head and
neck. Mod Pathol 2002;15:324–30.
32. Colville RJI, Camilleri IG, McLean NR, Soames JV. Malignant
peripheral nerve sheath tumour metastasizing to the parotid gland.
Br J Plast Surg 2003;57:418–20.
33. Burggraaff BA, Weinstein GS. Chondrosarcoma of the larynx.
Ann Otol Rhinol Laryngol 1992;101:183184.
34. Tran LM, Mark R, Meier R, Calcaterra TC, Parker RG.
Sarcomas of the head and neck. Prognostic factors and treatment
strategies. Cancer 1992;70:169–77.
35. Nasri S, Mark RJ, Sercarz JA, Tran LM, Sadeghi S. Pediatric
sarcomas of the head and neck other than rhabdomyosarcoma.
Am J Otolaryngol 1995;3:165–71.
